73 related articles for article (PubMed ID: 501863)
1. Long-term cloprednol use in chronic asthma.
Gavani UD; Hyde JS; Khurana S; Manaligod LM
JAMA; 1979 Dec; 242(24):2679-82. PubMed ID: 501863
[TBL] [Abstract][Full Text] [Related]
2. Cloprednol therapy in steroid-dependent asthma.
Shapiro GG; Tattoni DS; Kelley VC; Pierson WE; Dorsett CS; Bierman CW
Pediatrics; 1979 May; 63(5):747-53. PubMed ID: 440895
[TBL] [Abstract][Full Text] [Related]
3. Short-term efficacy and side effects of cloprednol in children with asthma.
Ellis EF; Morris HG; Kiechel F; Pollock JD; Strand LJ
J Clin Pharmacol; 1979 Oct; 19(10):675-83. PubMed ID: 512064
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of cloprednol versus placebo in asthma.
Goodman DH
Ann Allergy; 1978 Jun; 40(6):376-80. PubMed ID: 352197
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety and hypothalamic-pituitary-adrenal axis function in patients with asthma treated with cloprednol.
Miskovits G; Rado JP; Toth A; Zolnay E
Respiration; 1979; 38(6):345-52. PubMed ID: 231809
[TBL] [Abstract][Full Text] [Related]
6. Does alternate-day cloprednol therapy prevent bone loss? A longitudinal double-blind, controlled clinical study.
Medici TC; Rüegsegger P
Clin Pharmacol Ther; 1990 Oct; 48(4):455-66. PubMed ID: 2225706
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cloprednol and prednisolone in chronic asthmatic patients.
Ellul-Micallef R; Fenech FF; Parrott D
Br J Clin Pharmacol; 1978 Jul; 6(1):91-3. PubMed ID: 352380
[No Abstract] [Full Text] [Related]
8. Effects of cloprednol and other corticosteroids on hypothalamic-pituitary-adrenal axis function.
Ortega E; Rodriguez C; Strand LJ; Segre E
J Int Med Res; 1976; 4(5):326-37. PubMed ID: 1028634
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma.
Zora JA; Zimmerman D; Carey TL; O'Connell EJ; Yunginger JW
J Allergy Clin Immunol; 1986 Jan; 77(1 Pt 1):9-13. PubMed ID: 3944378
[TBL] [Abstract][Full Text] [Related]
10. Personal observations on the use of inhaled corticosteroid drugs for chronic asthma.
Toogood JH; Jennings B; Baskerville J; Lefcoe NM
Eur J Respir Dis; 1984 Jul; 65(5):321-38. PubMed ID: 6378649
[TBL] [Abstract][Full Text] [Related]
11. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
Abeyagunawardena AS; Hindmarsh P; Trompeter RS
Arch Dis Child; 2007 Jul; 92(7):585-8. PubMed ID: 17284479
[TBL] [Abstract][Full Text] [Related]
12. Long-term study of cloprednol in asthmatic patients.
Miskovits G; Toth A; Parrott D
Respiration; 1984; 45(2):147-53. PubMed ID: 6374803
[TBL] [Abstract][Full Text] [Related]
13. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.
Keatings VM; Jatakanon A; Worsdell YM; Barnes PJ
Am J Respir Crit Care Med; 1997 Feb; 155(2):542-8. PubMed ID: 9032192
[TBL] [Abstract][Full Text] [Related]
14. Cloprednol bioavailability in humans.
Mroszczak EJ; Runkel R; Strand LJ; Tomlinson RV; Fratis A; Segre E
J Pharm Sci; 1978 Jul; 67(7):920-3. PubMed ID: 660508
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma.
Lock SH; Kay AB; Barnes NC
Am J Respir Crit Care Med; 1996 Feb; 153(2):509-14. PubMed ID: 8564089
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of cloprednol.
Möllmann H; Hochhaus G; Rohatagi S; Barth J; Derendorf H; Krieg M; Weisser H; Möllmann AC
Int J Clin Pharmacol Ther; 1996 Jan; 34(1):1-5. PubMed ID: 8688990
[TBL] [Abstract][Full Text] [Related]
17. Metabolic effects of cloprednol-a new systemic corticosteroid.
Ortega E; Rodriguez C; Strand LJ; Bessler S; Segre E
J Clin Pharmacol; 1976; 16(2-3):122-8. PubMed ID: 1254734
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroid therapy in asthma.
Dunlap NE; Fulmer JD
Clin Chest Med; 1984 Dec; 5(4):669-83. PubMed ID: 6151441
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
[TBL] [Abstract][Full Text] [Related]
20. Budesonide: a new corticosteroid in bronchial asthma.
Ellul-Micallef R; Hansson E; Johansson SA
Eur J Respir Dis; 1980 Jun; 61(3):167-73. PubMed ID: 7002575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
